Senti Biosciences, Inc. financial data

Symbol
SNTI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2 Corporate Drive, First Floor, South San Francisco, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Dynamics Special Purpose Corp. (to 6/13/2022)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 603 % -5.81%
Debt-to-equity 76.1 % +83.5%
Return On Equity -175 % -85.8%
Return On Assets -99.3 % -49.3%
Operating Margin -27.3K % -1781%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.58M shares -89.7%
Common Stock, Shares, Outstanding 4.57M shares -89.7%
Entity Public Float 30.2M USD
Common Stock, Value, Issued 1K USD -75%
Weighted Average Number of Shares Outstanding, Basic 4.57M shares +3.26%
Weighted Average Number of Shares Outstanding, Diluted 4.57M shares +3.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 338K USD -91.6%
Revenue from Contract with Customer, Excluding Assessed Tax 255K USD -91.6%
Research and Development Expense 36.1M USD +43.3%
General and Administrative Expense 30.5M USD -18.8%
Operating Income (Loss) -92.2M USD -57.1%
Nonoperating Income (Expense) 13.6M USD +217%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -109M USD +2.65%
Earnings Per Share, Basic 0.33 USD/shares +41.9%
Earnings Per Share, Diluted 0.33 USD/shares +41.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.9M USD -56.8%
Cash, Cash Equivalents, and Short-term Investments 35.9M USD -63.6%
Accounts Receivable, after Allowance for Credit Loss, Current 567K USD
Other Assets, Current 20K USD -85.6%
Assets, Current 44.3M USD -30.2%
Property, Plant and Equipment, Net 23.3M USD -60.5%
Operating Lease, Right-of-Use Asset 15.3M USD -12.4%
Other Assets, Noncurrent 76K USD -80.7%
Assets 86.9M USD -39.5%
Accounts Payable, Current 1.18M USD -54.3%
Employee-related Liabilities, Current 1.34M USD -36%
Accrued Liabilities, Current 3.97M USD +396732%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 9.07M USD -13%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 31.3M USD -12.1%
Liabilities 42.8M USD -7.46%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -268M USD -27%
Stockholders' Equity Attributable to Parent 44.1M USD -54.7%
Liabilities and Equity 86.9M USD -39.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD +28.3%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -9.5M USD -28.7%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 4.57M shares -89.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.7M USD +54.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.4M USD -51.6%
Deferred Tax Assets, Valuation Allowance 61.3M USD +45.7%
Cash and Cash Equivalents, Period Increase (Decrease) -493K USD
Deferred Tax Assets, Gross 64.8M USD +41.1%
Operating Lease, Liability 35.6M USD -6.45%
Depreciation 984K USD +111%
Payments to Acquire Property, Plant, and Equipment 15K USD -99.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -57M USD +21.2%
Lessee, Operating Lease, Liability, to be Paid 49M USD -12.7%
Property, Plant and Equipment, Gross 31.1M USD -50.7%
Operating Lease, Liability, Current 4.33M USD +76.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.71M USD +3.13%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.48M USD +3.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.4M USD -20.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.77M USD -25.2%
Deferred Tax Assets, Operating Loss Carryforwards 33.6M USD +32.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.08M USD +26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.86M USD -15.8%
Additional Paid in Capital 312M USD +1.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5.15M USD -59.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%